ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $278 | -48.8% | 13,017 | -3.2% | 0.00% | -50.0% |
| Q1 2023 | $543 | -13.9% | 13,444 | -0.9% | 0.01% | -25.0% |
| Q4 2022 | $631 | -99.9% | 13,568 | +0.6% | 0.01% | -11.1% |
| Q3 2022 | $699,000 | +6.1% | 13,488 | -3.3% | 0.01% | +12.5% |
| Q2 2022 | $659,000 | -27.0% | 13,945 | +9.8% | 0.01% | -20.0% |
| Q1 2022 | $903,000 | -5.1% | 12,695 | -0.4% | 0.01% | +11.1% |
| Q4 2021 | $952,000 | +27.8% | 12,740 | -2.9% | 0.01% | +28.6% |
| Q3 2021 | $745,000 | +36.2% | 13,125 | +5.5% | 0.01% | +16.7% |
| Q2 2021 | $547,000 | -8.7% | 12,435 | +2.3% | 0.01% | -14.3% |
| Q1 2021 | $599,000 | +2.4% | 12,153 | -12.6% | 0.01% | 0.0% |
| Q4 2020 | $585,000 | -23.4% | 13,903 | -16.8% | 0.01% | -22.2% |
| Q3 2020 | $764,000 | -0.4% | 16,703 | +9.3% | 0.01% | -10.0% |
| Q2 2020 | $767,000 | +0.7% | 15,283 | +3.1% | 0.01% | -16.7% |
| Q1 2020 | $762,000 | +2.3% | 14,823 | +22.8% | 0.01% | +20.0% |
| Q4 2019 | $745,000 | +1.4% | 12,068 | -1.5% | 0.01% | 0.0% |
| Q3 2019 | $735,000 | +60.8% | 12,249 | +125.9% | 0.01% | +25.0% |
| Q2 2019 | $457,000 | -9.7% | 5,422 | +2.2% | 0.01% | -11.1% |
| Q1 2019 | $506,000 | +35.3% | 5,307 | +0.5% | 0.01% | +28.6% |
| Q4 2018 | $374,000 | -13.8% | 5,282 | +3.9% | 0.01% | 0.0% |
| Q3 2018 | $434,000 | -20.8% | 5,082 | +7.4% | 0.01% | -30.0% |
| Q2 2018 | $548,000 | +46.1% | 4,730 | +1.9% | 0.01% | +25.0% |
| Q1 2018 | $375,000 | +125.9% | 4,640 | +63.4% | 0.01% | +100.0% |
| Q4 2017 | $166,000 | +29.7% | 2,840 | +3.3% | 0.00% | -33.3% |
| Q3 2017 | $128,000 | +30.6% | 2,750 | +0.7% | 0.01% | -14.3% |
| Q2 2017 | $98,000 | +108.5% | 2,730 | +77.3% | 0.01% | +133.3% |
| Q1 2017 | $47,000 | -6.0% | 1,540 | +2.7% | 0.00% | -40.0% |
| Q4 2016 | $50,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 564,102 | $42,184,000 | 14.63% |
| Fairmount Funds Management LLC | 387,400 | $28,970,000 | 9.55% |
| Soleus Capital Management, L.P. | 318,275 | $23,801,000 | 2.38% |
| Darwin Global Management, Ltd. | 166,190 | $12,428,000 | 1.90% |
| Paradigm Biocapital Advisors LP | 75,507 | $5,646,000 | 1.61% |
| ARMISTICE CAPITAL, LLC | 1,056,000 | $78,968,000 | 1.29% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 150,000 | $11,217,000 | 1.29% |
| Portland Global Advisors LLC | 75,869 | $5,673,000 | 0.95% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 | $117,691,000 | 0.59% |
| Yorktown Management & Research Co Inc | 10,400 | $778,000 | 0.52% |